Form 8-K - Current report:
SEC Accession No. 0001193125-09-077237
Filing Date
2009-04-10
Accepted
2009-04-10 16:16:04
Documents
3
Period of Report
2009-04-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 19961
2 THIRD AMENDMENT TO LOAN AND SECURITY AGREEMENT DATED APRIL 6, 2009 dex101.htm EX-10.1 13849
3 FOURTH AMENDMENT TO AND ASSUMPTION OF LOAN AND SECURITY AGREEMENT dex102.htm EX-10.2 48614
  Complete submission text file 0001193125-09-077237.txt   84150
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22873 | Film No.: 09745257
SIC: 2835 In Vitro & In Vivo Diagnostic Substances